Androgen-deprivation therapy (ADT) for prostate cancer (PCa) has side effects that significantly impair health-related quality of life (HRQOL). Exercise ameliorates many side effects of ADT, but different modalities, particularly in the home-based setting, have not been well studied. In this study the authors randomly assigned 66 PCa survivors receiving ADT to 6 mo of home-based aerobic or resistance training. Psychosocial well-being and physical fitness were measured at baseline, 3 and 6 mo, and then 6 mo postintervention. Intention-to-treat analyses showed that fatigue and HRQOL were not significantly different between groups; however, in a per-protocol analysis the resistance-exercise training group demonstrated clinically significant improvements in HRQOL. Differential within-group effects on physical fitness were also observed at various time points. At all time points, the aerobic-training group engaged in significantly more physical activity than the resistance-training group, a finding that should be further examined given evidence-based guidelines for activity volume in cancer survivors.
fitness, and fatigue/vigor (Alibhai, Gogov, & Allibhai, 2006) . Physical exercise has been recommended to mitigate the detrimental effects of ADT and preserve physical and psychological well-being.
Studies that have examined the effect of physical activity and exercise during ADT have found improvements in lean and fat mass, muscle strength, overall physical activity volume, fatigue, and HRQOL (Thorsen, Courneya, Stevinson, & Fossa, 2008) . These benefits have arisen from pure resistance-exercise training (RET; e.g., Galvao, Taaffe, Spry, Joseph, & Newton, 2010) , home-based mixedmodality training (RET + aerobic exercise training [AET] ; Culos-Reed, Robinson, Lau, O'Connor, & Keats, 2007; Culos-Reed et al., 2010) , and facility-based mixedmodality training . While greater HRQOL and fitness benefits have thus far been associated with facility-based rather than home-based programs, the cost of providing exercise programs at cancer centers is a barrier that severely limits program delivery and access. The obstacles of travel time, parking costs, and negative hospital treatment experiences may reduce patient participation in facilitybased exercise programs (Craike, Livingston, & Botti, 2011; Demark-Wahnefried, 2007) . Based on both cost-effectiveness and access, home-based programming appears to be the preferred option for the maintenance of chronic exercise adherence. This is critical for patients receiving ADT because the treatment (and side effects) may be experienced for the remainder of their life span.
The American College of Sports Medicine recommends 150 min of moderate to vigorous physical activity per week for cancer survivors during and after treatment (Schmitz et al., 2010) . Specifically for PCa survivors, general guidelines of AET and RET have been provided based on the current availability of exercise literature for this population (Santa Mina, Ritvo, Segal, Culos-Reed, & Alibhai, 2010) but without much investigation of comparative benefit. References to existing literature are helpful but inconclusive. For example, Segal et al. (2009) conducted a three-arm, facility-based randomized controlled trial of 121 PCa patients treated with external beam radiation therapy, 61.2% (n = 74) of whom were also receiving ADT. Participants were randomized to 24 weeks of supervised RET or AET or a wait-list control group. While at the midpoint of the trial, RET and AET groups demonstrated improvements in fatigue compared with controls (p ≤ .01), only the RET group demonstrated improved fatigue compared with usual care at 24 weeks (p < .002). From baseline to 24 weeks, the RET group surprisingly experienced improved aerobic fitness and upper and lower body strength, while AET subjects only improved upper body strength (p ≤ .05). In a treatment-stratified analysis, the RET group (n = 17) improved upper and lower body strength (p ≤ .001) and reduced percentage body fat (p = .005), whereas the AET group (n = 15) only improved upper body strength (p = .02) when compared with controls. Although this analysis was exploratory and lacked adequate statistical power, the data suggested that RET may be more beneficial than AET for men treated with radiation and ADT. Given that this was a facility-based trial, there may be some differences with respect to modality preference and participation in a home-based setting. AET could be more effective in stimulating sustained changes in physical activity due to familiarity with common AET modalities (e.g., walking, jogging, and cycling). Consequently, there is a need to assess long-term changes in physical activity after home-based exercise interventions of different modalities. To date, only Culos-Reed et al. (2007) have conducted a postintervention follow-up after a 12-week home-based mixed-modality program for PCa survivors undergoing ADT. At 4 months postintervention, they found reductions in strenuous physical activity (p = .01) and concomitant worsening of fatigue (p = .07) and HRQOL (p = .04) compared with immediately after the exercise program, suggesting that the benefits of exercise are maintained only as long as the exercise is performed. This underscores the need for defining exercise interventions that are most amenable to permanent adoption.
At present, the modality-specific effects of AET and RET for ADT patients are poorly understood. While each modality presents independent hypothetical advantages for health and well-being in this population, they have not been directly compared in the home-based setting, which may be most amenable to long-term adherence. Therefore, the purpose of this study was to compare the effects of a 6-month home-based AET or RET intervention on HRQOL, fatigue, physical activity, and fitness outcomes with a 6-month postintervention follow-up in PCa survivors undergoing ADT.
Methods

Trial Design
This study was a prospective randomized trial of home-based AET versus RET. Concealed randomization was conducted using sequentially numbered opaque envelopes containing group assignments that were provided to participants after the baseline assessment. Training staff, outcome assessors, and participants were unblinded to group allocation. The study was approved by the institutional research ethics review committees, and all participants provided written informed consent before participation.
Participants
Eligible patients were approached for participation by a research coordinator after a urology clinic appointment at a tertiary care center in Toronto, ON, Canada, between June 2009 and July 2010. Patients could also respond to study information posters located in the clinic waiting areas. Patients were eligible if they had histologically confirmed PCa, were currently receiving ADT for a planned duration of the study period (12 months), had nonmetastatic disease, and were 45-95 years old. Patients were excluded if they had severe coronary artery disease (Canadian Cardiovascular Society Class III or greater), uncontrolled hypertension, severe congestive heart failure (New York Heart Association Class III or greater), uncontrolled pain, neurological or musculoskeletal ailments inhibiting exercise, or major psychiatric illness.
Exercise-Training Interventions
Participants were randomized to moderate-to vigorous-intensity home-based AET or RET for 6 months. The AET and RET prescriptions were of equivalent frequency (3-5 days/week), intensity (moderate to vigorous intensity for the respective modalities), and duration (30-60 min/session). Each group received a detailed exercise manual describing their exercise prescription, which was individualized according to the results of their baseline fitness assessment. The manual also included an exercise log book, information on the principles of exercise, and healthy behaviorchange support that has been previously used in home-based interventions with PCa patients receiving ADT (Culos-Reed et al., 2007; Culos-Reed et al., 2010) . In addition to the manual, a certified exercise physiologist provided each patient with detailed exercise instructions with demonstrations, as well as information regarding safety precautions. The exercise physiologist would make a call to the participants on alternate weeks that lasted approximately 5 min to provide encouragement for exercise and address any barriers to home-based intervention. Furthermore, during follow-up assessments and booster sessions, necessary adaptations and progressions to the exercise prescription were made based on the evaluation of the exercise physiologist.
AET Intervention
Participants in the AET group could select any modality of aerobic exercise available to them, while the standard recommendation focused on walking. AET was prescribed at an intensity of 60-80% of heart-rate reserve using the measured maximum heart rate from the baseline assessment. To monitor heart rate and provide an individualized exercise prescription, participants were provided with a heart-rate monitor (Polar Heart Rate Monitor FS2, Kempele, Finland) set to audibly indicate when they were outside of the prescribed training zone. Their training zone was based on their measured resting and maximal heart rate. Furthermore, if participants preferred nonwalking aerobic exercise such as swimming or cycling, they were provided with instructions on how to manually measure heart rate (in cases where activities were water-based), as well as various modality-specific safety tips and route preparation (for activities like cycling). The training zone of the AET prescription was not advanced during the intervention; however, participants were encouraged to first extend their training sessions by 5-10 min and then strive to attain higher heart rates within their training zone. Due to improved fitness and exercise efficiency, the participants would require a greater effort to achieve their training zone, so intensity progression to maintain a heart rate within the zone would naturally occur.
RET Intervention
RET participants received three resistance bands (light, moderate, and heavy resistance), an exercise mat, and a stability ball. RET was performed for two or three sets of 8-12 repetitions each at an intensity of 12-15 on a rating of perceived exertion scale (approximately 60-80% of one-repetition maximum). Initial intensity was based on the performance of the exercises during the exercise-prescription session. For each RET exercise, three levels of intensity (beginner, intermediate, and advanced) were provided in the manual and explained during the baseline demonstration to accommodate different levels of physical fitness. Individualization to the exercise prescription for RET participants was provided by indicating which classification for each exercise the participant was currently able to do and a goal for program progression (i.e., the beginner, or green, resistance band to intermediate, or blue, resistance band). Participants were instructed to increase their exercise intensity to the next intensity level once they could complete 12 repetitions without significant muscle fatigue. The resistance exercises were ball squats, hamstring curls, push-ups, upright rows, triceps extensions, bicep curls, seated row, lateral raises, abdominal crunches on the ball, and hip extensions.
Booster Sessions
To promote exercise adherence and address barriers to exercise, participants of the AET and RET groups were encouraged to attend group-based booster sessions every other week over the 6-month intervention (total of 12 sessions). Each 1.5-hr session included a 1-hr training component and a 30-min education/discussion component previously used in a population of ADT-treated PCa survivors (Culos-Reed et al., 2007 . The education/discussion period addressed various topics related to exercise participation and long-term adherence, such as goal setting, barriers to exercise, and social support. To ensure that booster session attendees were exposed to group dynamics and socially supportive opportunities among peers, AET and RET participants attended the booster sessions together, which consisted of equivalent AET and RET durations (20 min each) with a 10-min warm-up and cooldown.
Assessments and Outcomes
Participants completed four study assessments: baseline, midintervention (3 months), postintervention (6 months), and postintervention follow-up (12 months). Participants' demographic information, disease staging, comorbidity status, and ADT regimen were collected at baseline only. Comorbidity was assessed using the Charlson Index (Charlson, Pompei, Ales, & MacKenzie, 1987) . Disease-specific HRQOL was assessed using the Functional Assessment of Cancer TherapyProstate (FACT-P; Esper et al., 1997) and the Patient-Oriented Prostate Utility Scale (PORPUS; Krahn et al., 2000) . Fatigue was examined using the Functional Assessment of Cancer Therapy-Fatigue (FACT-F; Cella, 1997) . The minimal clinically important differences on the FACT-P and FACT-F are 5.5 and 3.5 points, respectively. HRQOL and fatigue-questionnaire data were oriented to indicate HRQOL and fatigue improvement with increasing scores. Exercise adherence was measured by attendance at the booster sessions and physical activity volume measured by the Godin Leisure-Time Exercise Questionnaire-Leisure Score Index (GLTEQ; Godin & Shephard, 1985) . The GLTEQ is a 3-item measure that assesses the frequency of mild, moderate, and strenuous bouts of leisure physical activity or exercise performed for at least 15 min over the past week. To provide data in MET-hr/week that could yield insight into the activity volume relative to guidelines, the questionnaire was modified in each item by adding the specific duration for each intensity as per the previous work by previous groups (e.g., Courneya, Friedenreich, Quinney, et al., 2003; Vallance, Courneya, Plotnikoff, Yasui, & Mackey, 2007 ). An independent evaluation confirmed its reliability and validity compared with nine other self-report measures of exercise participation. Specifically, The GLTEQ demonstrated a 1-month test-retest reliability of .62 and concurrent validity coefficients of .32 with accelerometer-assessed physical activity, .56 directly measured VO 2peak , and -.43 with percentage body fat (Jacobs, Ainsworth, Hartman, & Leon, A.S., 1993) . The GLTEQ has been widely used with cancer patients and survivors participating in exercise interventions (Courneya, Blanchard, & Laing, 2001; Courneya, Booth, et al., 2008; Courneya & Friedenreich, 1997 , 1998 Courneya, Friedenreich, Quinney, et al., 2003; Courneya et al., 2009; Courneya, Friedenreich, Sela, et al., 2003; Courneya, Jones, et al., 2008; Courneya, Mackey, et al., 2003; Courneya, McKenzie, et al., 2008; Courneya et al., 2007) , including PCa patients receiving ADT (Culos-Reed et al., 2007; Culos-Reed et al., 2010) . A change of 15 MET-hr/week was considered clinically significant given its correspondence with American College of Sports Medicine guidelines for physical activity in cancer survivors (Schmitz et al., 2010) .
Aerobic fitness was estimated by indirect measurement of peak oxygen consumption (VO 2peak ) using the modified Bruce treadmill protocol (Lerman, Bruce, Sivarajan, Pettet, & Trimble, 1976) . The modified Bruce treadmill protocol was selected because it uses a prolonged warm-up and walking (rather than running) combined with increases in grade to bring participants to maximum intensity. The protocol requires participants walk at 1.7-3.7 miles/hr (~3-6 km/hr) at elevations from 0% to 18% grade, with speed and/or grade increased every 3 min to a point of subjectively described maximal effort using a 10-point rating of perceived exertion scale (Borg, 1998) . VO 2peak was subsequently estimated using the final speed and grade that the participant accomplished and the American College of Sports Medicine metabolic equations for estimating gross VO 2 for walking (American College of Sports Medicine, 2005). Grip strength was assessed using a Jamar grip dynamometer (Sammons Preston, Bolingbrook, IL, USA). Participant height and weight were recorded and used to calculate body-mass index (BMI). Waist circumference was measured at the narrowest aspect of the torso, between the ribs and iliac crest. Percentage body fat was calculated from the sum of three skinfolds (chest, abdomen, and thigh) using Harpenden calipers (FitSystems Inc., Calgary, AB, Canada; Jackson & Pollock, 1978) . Given that gynecomastia occurs in almost one in five men undergoing ADT (Sharifi, Gulley, & Dahut, 2005) , chest skinfold thickness (diagonal skinfold between the midpoint and the axilla) was also assessed as a secondary endpoint.
Statistical Analysis
The primary outcomes for this study were between-groups differences and Group × Time interaction at 6 months for the FACT-F, FACT-P, and PORPUS. Baseline comparisons between the AET and RET groups were performed using independentsamples t tests for continuous variables and χ 2 analyses for categorical variables. In a fashion similar to that of Segal et al. (2009) , the analyses of within-group contrasts at baseline to 3, 6, and 12 months were conducted using paired-sample t tests. Pairedsample t tests were also used assess changes from postintervention (6 months) to the 12-month follow-up. Analysis of covariance (ANCOVA) was employed to assess between-groups changes from baseline to 3 and 6 months, controlling for the baseline value of the dependent variable in the model. A repeated-measures analysis of variance (ANOVA) was used to evaluate the group main effect from baseline to 3, 6, and 12 months, as well as Group × Time interaction.
An intention-to-treat analysis was conducted using the last value carried forward technique. A per-protocol analysis was also conducted, including only the participants who completed baseline, 6-month, and 12-month assessments. Data were analyzed using the Statistical Package for Social Sciences software, version 19.0 (IBM, Armonk, NY). Test statistics (t, F, χ 2 ) are presented when p ≤ .05. Effect-size statistics (partial η 2 ) are presented where appropriate.
Results
Participant Characteristics and Participation
The CONSORT diagram for the study is presented in Figure 1 . Briefly, we recruited n = 66 (32%) of the 205 eligible participants we approached. The 66 participants were randomly assigned to AET (n = 32) or RET (n = 34). Baseline participant characteristics are presented in Table 1 . The groups were similar at baseline in all studied variables (p > .05). From baseline to 6 months, attrition rates were 26% and 44% for the AET and RET groups, respectively. There was no statistical difference in attrition rate from baseline to 6 months between the AET and RET groups (p = .164). In the AET group, reasons for dropout were disease progression inhibiting continued participation (n = 1), loss of interest/motivation (n = 1), too far to travel for assessments (n = 1), symptoms/comorbidities interfered with exercise participation (n = 2), and no time (n = 4). In addition, 4 patients were lost to follow-up without explanation. For the RET group, reasons for dropping out were advanced disease inhibiting continued participation (including deceased; n = 3), loss of interest/motivation (n = 3), too far to travel for assessments (n = 3), symptoms or comorbidities interfered with exercise participation (n = 4), and no time (n = 2). In addition, 7 patients were lost to follow-up without explanation. There were no differences in the baseline characteristics between those who dropped out before the 6-month follow-up versus after the 6-month follow-up (data not shown).
The AET and RET groups attended, respectively, a mean of 16.4% and 5.5% of the booster sessions, (t = -2.06, p = .045). It should be noted that 27 AET participants and 22 RET participants did not attend any booster sessions, indicating the overall poor attendance at these sessions. There were no serious adverse events related to the exercise intervention in either group beyond the expected delayedonset muscle soreness associated with engaging in novel exercise.
Primary and Secondary Outcomes
Within and between-groups results for all study outcomes from baseline to 6 months are presented in Table 2 .
HRQOL and Fatigue
The AET group demonstrated a trend toward modest worsening in fatigue at 3 months measured by the FACT-F (mean change = -1.3, SEM 0.77, p = .083). From 6 months to 12 months, the AET group demonstrated a trend toward increased HRQOL via the PORPUS (mean change = 1.7, SEM = 0.89, p = .074). There were no within or between-groups changes for HRQOL or fatigue at any other time point. There were no Group × Time interactions for HRQOL or fatigue at 3, 6, and 12 months as indicated by the repeated-measures ANOVA (data not shown). Note. AET = aerobic-exercise training; RET = resistance-exercise training; FACT-F = Functional Assessment of Cancer Therapy-Fatigue; FACT-P = Functional Assessment of Cancer Treatment-Prostate; PORPUS = Patient-Oriented Prostate Utility Scale; MET = metabolic equivalent; LHRH-a = luteinizing hormone-releasing hormone agonist. 
Physical Activity and Fitness
Significant within-group improvements from baseline to 3 months were observed in the AET group for weight (t = -2.66, p = .013), waist circumference (t = -2.69, p = .012), BMI (t = -2.61, p = .014), chest skinfold thickness (t = -2.45, p = .02), and physical activity volume (t = 2.55, p = .016), with a trend toward decreased percentage body fat (p = .054). No within-group changes from baseline to 3 months were observed in the RET group. From baseline to 6 months, the AET group demonstrated significant increase in physical activity volume (t = 3.06, p = .005), with trends toward significance for a decreased waist circumference (p = .067), chest skinfold (p = .061), and percentage body fat (p = .095). At 6 months, the RET group demonstrated significant improvement in VO 2peak from baseline (t = 2.682, p = .011).
Between-groups differences in mean change from baseline at 3 months were observed for weight (AET = -1.6 kg vs. RET = 0.2 kg, 95% CI: -3.24 to 0.20), waist circumference (AET = -1.3 cm vs. RET = 0.1 cm, 95% CI: -3.07 to -0.03), BMI (AET = -1.4 kg/m 2 vs. RET = 0.1 kg/m 2 , 95% CI: -1.037 to -0.06), and physical activity volume (AET = 13.8 MET-hr/week vs. RET = -0.2 MET-hr/week, 95% CI: 0.35-24.68). At 6 months, the mean change in physical activity volume from baseline was greater for the AET group than for the RET group (AET = 16.8 MET-hr/week vs. RET = 2.8 MET-hr/week, 95% CI: 1.56-27.07). There were no other between-groups differences in mean change for any other outcomes at 6 months (data not shown).
From baseline to 12 months, the AET group improved physical activity volume (mean change = 13.8 MET-hr/week, SEM = 4.3, t = 3.239, p = .003), waist circumference (mean change = -1.4 cm, SEM = 0.61, t = -2.28, p = .03), and percentage body fat (mean change = -1.9%, SEM = 0.87, t = -2.287, p = .029). There was a trend toward improved VO 2peak in the AET group from baseline to 12 months (mean change = 2.4 ml · kg -1 · min -1 , SEM = 1.8, p = .056) and chest skinfold thickness (-2.3 mm, SEM = 6.7, p = .061). For the RET group, a trend toward improvement in chest skinfold thickness (mean change = 2.5 mm, SEM = 1.4, p = .082) and percentage body fat (mean change = 1.9%, SEM = 5.4, p = .058) was observed from baseline to 6 months postintervention. During the postintervention followup period (Months 6-12), the RET group demonstrated a significant decrease in percentage body fat (mean change = -1.4%, SEM = 2.9, t = -2.29, p = .014). No other significant changes from baseline to 6 months or 12 months were observed in either group (data not shown).
From baseline to 12 months, a between-groups difference in mean change was observed for physical activity volume (AET 13.9 MET-hr/week vs. RET 2.5 MET-hr/week, 95% CI: 0.68-21.59, p = .037). There were no other between-groups differences in mean change from baseline to 12 months or from 6 to 12 months for any other study outcomes. There were no Group × Time interactions in the intention-to-treat analysis for physical activity or any fitness outcomes from baseline to any time point as indicated by the repeated-measures ANOVA (data not shown). Table 3 presents the within-and between-groups changes of the study outcomes at 6 and 12 months for the participants who completed the 6-and/or 12-month assessments. From baseline to 6 months, the AET group increased physical activity Note. Within-group analysis: †Significant change from baseline (p ≤ .05). ‡Significant change from baseline (p ≤ .01). §Significant change from 6 to 12 months.
Per-Protocol Analysis
Table 3 (continued)
volume by approximately 21.5 MET-hr/week (t = 2.82, p = .01) and VO 2peak by 3.0 ml · kg -1 · min -1 (t = 2.34, p = .03). Over the same period, the RET group increased their VO 2peak by 3.8 ml · kg -1 · min -1 (t = 2.85, p = .011) and decreased chest skinfold thickness by 4 mm (t = -2.58, p = .018). During the follow-up period (Months 6-12), there was a significant reduction in percentage body fat for RET participants (-3.0%, t = 3.0, p = .012). From baseline to the end of the follow-up period, the AET group demonstrated reductions in waist circumference (-1.84 cm, t = 2.25, p = .037) and percentage body fat (-3.3%, t = 2.77, p = .013) while increasing total physical activity volume (+13.7 MET-hr/week, t = 2.24, p = .038). Analysis by repeated-measures ANOVA indicated a significant Group × Time interaction for the PORPUS, F(1, 23) = 3.43, p = .022, partial η 2 = 0.130. This was driven by a significant within-group improvement in PORPUS-rated HRQOL at 12 months compared with baseline (+8.1 points, t = 3.3, p = .008), which was significantly different from the AET group (F = 6.02, p = .021). No other per-protocol betweengroups differences or interactions were observed in study outcomes during any of these time periods.
Discussion
Although previous comparisons of facility-based AET and RET have been made in populations with cancer (Courneya et al., 2007; Segal et al., 2009) , to our knowledge this is the first comparison of AET to RET in a home-based setting. In our population of men with PCa receiving ADT, we found that HRQOL and fatigue were relatively unchanged with either exercise program. This is consistent with findings from previous home-based physical activity interventions in this population (Carmack Taylor et al., 2006; Culos-Reed et al., 2010) . However, we did find that physical activity volume was greater in the AET than in the RET from baseline to 3, 6, and 12 months. We also found that AET had superior effects with respect to reductions in weight, waist circumference, and BMI at 3 months compared with RET. It is interesting that RET was associated with improvements in VO 2peak at 6 months compared with baseline while AET had no statistically significant effect on aerobic fitness at any time point in an intention-to-treat analysis. The results of this study suggest that AET may be a more effective intervention in initiating long-term changes in physical activity volume in PCa survivors, as clinically meaningful increases in physical activity volume were observed in the intention-to-treat and per-protocol analysis throughout the intervention period and at 6 months postintervention. The common modes of AET (e.g., walking) are more familiar to patients than RET and more easily reproducible in the absence of the routine instruction or demonstration required for RET. Furthermore, the home-based AET prescription provided in this study (primarily walking) could more readily be shared with a partner, friend, or other family member than the RET program. This would be consistent with studies describing walking as a preferred modality for exercise among cancer survivors (Jones & Courneya, 2002; Jones et al., 2007) .
Although consistent differences were seen between AET and RET in terms of physical activity volume, it should be noted that self-report measures of physical activity may be vulnerable to social desirability. Log books were also used to assess overall compliance with the exercise prescription but could not be reliably analyzed because too few participants completed them effectively. Furthermore, the GLTEQ may not be sensitive to changes in physical activity volume in an RET intervention, given conventional descriptions of physical activity, and to our knowledge this measure has not been specifically validated for RET. In the current study we used the GLTEQ as an open-ended question about the frequency and duration of strenuous, moderate, or mild exercise. In the original GLTEQ, the intensities of exercise are paired with a variety of examples of athletic and general physical activity (e.g., running, swimming, or golf), and we must acknowledge that the original GLTEQ does not contain examples of RET. This may undermine its content validity for this modality, as participants may not be able to accurately reflect on their RET activities in the appropriate intensity designation. This is a noted limitation in many exercise questionnaires (Shephard, 2003) and a potential explanation for the discrepancy in physical activity volume seen between the groups. Objective assessments of physical activity such as doubly-labeled water techniques and accelerometry would produce more definitive evidence regarding physical activity status but were cost-prohibitive in the context of this study. However, at 3 and 12 months, changes in physical activity volume were accompanied by beneficial changes in body composition that are suggestive of actual improvements in physical activity rather than simple response bias.
Our findings contrast with the comparison by Segal et al. (2009) of facilitybased AET and RET with usual-care controls. In that study, they found that RET was more consistently associated with physical fitness and HRQOL benefits, whereas we found that AET demonstrated greater benefit (vs. RET), particularly at 3 months. The training provided to participants in the Segal et al. trial was facility-based and closely supervised; participants could receive instruction and support throughout their training regimen, likely reducing the learning curve for the RET program. Furthermore, progression in intensity was better operationalized, facilitating earlier advancement, because incremental increases in intensity were based on repetitions at a specified weight. Our study may not have produced similar training effects in the RET group due to a lower training intensity via resistance bands and possibly slower prescription adaptation as we relied on subjective cues of progression (i.e., when 12 repetitions at a given band intensity became easy) that are less concrete.
On the other hand, we did observe findings similar to those of Segal et al. (2009) with respect to improved aerobic fitness and percentage body fat at 6 months for the RET. While change in body fat is an expected result of RET, the improved aerobic capacity in RET rather than AET is surprising and may be due to a combination of factors. First, AET can be completed by simply increasing walking frequency and intensity as a matter of general physical activity or incorporation into commuting patterns. In the absence of information specifically regarding contamination in the RET group, we cannot conclusively determine whether they walked (or engaged in other AET activity) more frequently, as well. However, Segal et al. reported that n = 8 RET participants engaged in AET ≥3 times per week versus n = 5 AET participants engaged in RET ≥2 times per week, demonstrating that AET may be more frequently integrated into an RET program, in contrast to the reverse integration. The alternative hypothesis is that, while AET is likely to improve overall oxygen consumption by facilitating cardiorespiratory adaptation, the observed change in aerobic capacity in the RET group as measured may be due to improved lower extremity strength and subsequent increased capacity to complete the graded exercise test on a treadmill. Graded exercise testing for aerobic capacity using a treadmill relies on systematic increases in speed and incline. Participants engaged in home-based AET (without a treadmill) may not have routine access to walking routes that consist of significant elevations in grade and thus fail to stimulate neuromuscular adaptation for walking at incline. However, RET participants are trained to specifically improve lower extremity strength, thus facilitating neuromuscular adaptation that would support deeper walking strides (i.e., greater knee flexion) common to inclined walking at >10% incline during a graded exercise test on a treadmill. To address this problem with measurement validity, future studies would optimally compare AET with RET using direct gas analysis to precisely determine true oxygen consumption, as well as measures of walking economy, rather than simply indirect estimates of VO 2peak .
Early research in exercise for ADT patients hypothesized to improve ADTrelated HRQOL and fatigue via physical and psychological benefits by improving functional capacity and cognitive resilience. Unfortunately, the magnitude of benefit observed in the initial assessment of exercise for ADT by Segal et al. (2003) has not been replicated. In fact, of the nine exercise trials in ADT patients that have employed a fatigue-specific outcome measure, only three have produced statistically significant improvements (Culos-Reed et al., 2007; Segal et al., 2003; Segal et al., 2009) . Two of those trials used RET (Segal et al., 2003 , Segal et al., 2009 , and only in one trial was the benefit observed to be clinically significant (Segal et al., 2003) . While our findings are congruent with most of the existing exercise literature with respect to null effects on fatigue, improvements in physical capacity may be more representative of physical fatigue than self-report measures. We did, however, observe that RET was associated with a clinically and statistically significant increase in disease-specific HRQOL measured by the PORPUS that was significantly greater than in the AET group in a per-protocol analysis. Our study was the first to use the PORPUS in an intervention-based exercise study in PCa patients, and it was interesting that we did not observe similar differences in HRQOL measured by the FACT-P. These findings must be interpreted with caution, because the sample comprised the most adherent and motivated participants. Furthermore, the discordance between PORPUS and FACT-P results necessitates further investigation in larger samples for cross-validation in exercising participants. Our findings that RET is more effective than AET at improving HRQOL are novel and in some contrast to Segal et al.'s (2009) findings of no change in HRQOL after 24 weeks of facility-based training in men undergoing radiation therapy and adjuvant ADT. However, it is consistent with other studies in PCa populations that demonstrate an improvement in disease-specific HRQOL with RET (Segal et al., 2003; Serdà, Monreal, & Del Valle, 2010) but not with AET (Windsor, Nicol, & Potter, 2004) or mixed-modality training (Bourke et al., 2011; Carmack Taylor et al., 2006; CulosReed et al., 2007; Culos-Reed et al., 2010) . Collectively, our results contribute to the ambiguous nature of the effects of exercise on psychosocial outcomes in PCa patients receiving ADT compared with the more universal observations of benefits to physical and functional measures of well-being (Thorsen et al., 2008) . Although these physical/functional changes have not consistently translated into perceptual benefits regarding fatigue and HRQOL, they may be more reliable in describing the direct effect of exercise. Additional research into the mechanisms and relationships between the physical and the cognitive, emotional, and psychological experience in this population is necessary.
The results of this study should be interpreted in light of additional limitations. The study was underpowered to conclusively demonstrate between-groups differences in RET and AET. Given the current status of exercise and PCa literature, this study provides an important initial assessment of comparable home-based exercise programming that examines multiple exercise modalities, as well as variance parameter estimates for future sample-size calculations to conduct adequately powered studies. Nonetheless, our findings require cautious interpretation due to the inadequate sample size. Second, the omission of a control group prevents a full understanding of how these exercise modalities compare with standard care; however, the evidence for the beneficial effects of exercise for cancer survivors, and PCa survivors in particular, suggests that both groups were likely to demonstrate significant improvements compared with nonexercising controls. Third, the significant attrition from baseline to 6 months, particularly in the RET group (although not statistically significant in comparison with the AET group), should be considered and represents a potential explanation for general lack of RET effect on many study outcomes. Fourth, we were unable to use the physical activity logbooks due to poor completion by a majority of the participants. This prevented us from identifying the specific type of exercise participants were engaged in (particularly for the AET group) or verifying physical activity volume provided by the GLTEQ, making it impossible to specifically assess compliance with the individualized exercise prescription or contamination between the two groups. In future comparisons of AET and RET, the GLTEQ may be most useful if respondents are instructed to complete the measure with respect to nonintervention activity. Fifth, we could not provide alternative exercise accommodations for inclement weather for the participants in the exercise group that conducted outdoor walking as their primary modality. While several AET participants conducted aerobic exercise using a mix of indoor and outdoor exercise modalities (e.g., indoor stationary cycling vs. neighborhood walking), general noncompliance with the exercise logbook impaired our ability to accurately assess how patients independently adapted their program due to environmental barriers. Consequently, we are not able to discern the variety of aerobic exercises that participants engaged in, nor were we able to specifically identify participants who employed free weights or exercise machines as an alternative to the exercise bands. While there may be methodological advantages to restricting the use of nonprogrammatic exercises, we would argue that confining a participant's choice of AET or RET options to only those in the research study significantly jeopardizes generalizability, because self-directed adaptation should be encouraged and supported as it is conducive to long-term behavior change. Finally, the booster sessions were poorly attended in contrast to previous home-based exercise programs in this population (Culos-Reed et al., 2007; Culos-Reed et al., 2010) . Participants cited various reasons for not attending, notably distance and travel time to the urbanbased group exercise classes. Furthermore, due to resource constraints and the risk of poor attendance resulting in one-on-one sessions with the training staff, it was not feasible or conducive to the intent of the sessions to provide booster sessions specific to AET and RET. This may have introduced a contaminant effect during these sessions, although two sessions per month would not likely produce relevant changes in outcome measurement given the limited attendance.
The study's strengths should also be highlighted. First, the novel aspect of home-based AET versus RET provides important information regarding the acceptability, safety, and efficacy of complementary exercise modalities. The value of assessing interventions with low institutional cost burden that may contribute to sustained exercise participation cannot be understated. This is also consistent with preference for home-based, unsupervised exercise programs among many cancer survivors (Jones & Courneya, 2002; Jones et al., 2007) . Second, outcomes were selected for direct comparison with other studies of exercise in ADT patients. Third, to enhance participants' adherence to the exercise program, we provided exercise equipment and manuals to each group that would support exercise throughout the intervention period and afterward. Fourth, the 6-month postintervention followup represents the longest follow-up period from a structured exercise intervention published to date. Fifth, we are the first to assess exercise-related changes in chest skinfold thickness in men undergoing ADT for PCa. Although ADT-induced gynecomastia is primarily due to changes in the glandular ducts, breast epithelial tissue, and periductal edema (McLeod & Iversen, 2000) , the size of the breast may be measured, in part, through a skinfold. In addition, the subcutaneous fat accumulation that arises systemically with ADT may contribute to the undesirable change in breast shape and size that is observed. Given the psychological distress associated with gynecomastia in ADT patients (Di Lorenzo, Autorino, Perdonà, & De Placido, 2005) , therapies such as exercise that may reduce the extent to which the breast is enlarged would be welcomed, as would investigations into the relationship between exercise and body image in this population.
It is important to assess the difference between AET and RET in this population for various reasons. Identifying the modality-specific benefits will aid exercise specialists in their development of tailored exercise prescriptions for men undergoing ADT, given their constellation of possible treatment side effects. This will allow men with PCa undergoing ADT to make priority-based decisions on the relative investment of time that they focus on competing modalities. Possibly most important, it is important to know which modality is most likely to yield chronic behavior change in this population, as ADT may be indicated for many years, possibly for the remaining years of the patient's life. This importance is verified by recent epidemiological evidence showing that men who exercise for ≥9 MET-hr/week after a diagnosis of PCa have a 33% and 35% reduction in allcause and PCa-related mortality, respectively (Kenfield, Stampfer, Giovannucci, & Chan, 2011) . This includes men who were sedentary before a PCa diagnosis, highlighting the importance of exercise initiation during or after treatment. These findings in addition to general exercise recommendations for cancer survivors are modality nonspecific, therefore supporting the idea that prescription that is most amenable to long-term compliance is essential. Men assigned to AET in the current trial increased their physical activity volume by 15-20 MET-hr/week, which may provide survival benefit if the behavior is maintained over time (Kenfield et al., 2011) . Physical activity volumes of approximately 35-40 MET-hr/week as observed in the AET group of this trial are consistent with cancer-specific recommendations of moderate to vigorous activities on most days and have been shown to reduce disease-specific mortality (Kenfield et al., 2011; Schmitz et al., 2010) .
Ultimately, a combination of AET and RET is likely to produce the most diverse array of benefits. A recent study completed by Galvao et al. (2010) examined the effect of a 12-week combined AET+RET intervention in a randomized controlled trial of 57 patients receiving ADT. Treatment group participants completed eight RET exercises at 6-12 RM (moderate to strenuous RET) for two to four sets per exercise. The AET component consisted of 15-20 min of cycling, walking, or jogging at 65-80% of maximum heart rate or 11-13 out of 20 on a rating of perceived exertion scale. Participants completed exercises in a facility-based, supervised setting in small groups of 1-5 participants. Primary outcomes were whole-body and regional lean mass measured by dual-energy X-ray absorptiometry. At the end of 12 weeks, the exercising participants demonstrated significantly greater lean mass, muscle strength, and functional capacity than controls (p ≤ .05). Over the course of the trial, exercising subjects also improved HRQOL, reduced fatigue, and reduced C-reactive protein (p < .025). This study was the first to demonstrate a reversal in muscle loss in androgen-suppressed PCa patients and to demonstrate significant HRQOL, fatigue, and muscle-strength outcomes with a mixed-modality exercise intervention. These important findings highlight the importance of a comprehensive and relatively intense exercise intervention for men with PCa receiving ADT. Future studies should address the chronic changes in physical and psychosocial outcomes, as well as exercise-maintenance strategies, that follow facility-based interventions. In the absence of continued follow-up and support, these benefits may diminish over time (Culos-Reed et al., 2007) , so it is important to develop strategies to enhance independent exercise, beyond the constraints of the health care system. Our study shows that few of the physical-fitness benefits achieved in the early intervention period are sustained for up to 12 months. Supporting home-based exercise may be a necessary component of exercise adherence over the long term.
Conclusion
Our trial demonstrates that home-based AET intervention was more effective at producing long-term, clinically significant increases in physical activity volume. In a per-protocol analysis, clinically significant improvements were observed for RET participants 12 months after baseline. Within-group analyses suggest differential effects of home-based AET and RET on several body-composition and physical-fitness measures. The results of this trial require confirmation from a more adequately powered, larger randomized trial.
